企業プロフィール
NeuroSense Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- NRSN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Israel and listed in the U
株価パフォーマンス
0.38 USD (+7.39%)
終値
最終更新: 2026年8月21日
28.9M USD
時価総額
株価変動の要因
As of Aug 21, 2026, NRSN closed up 7.39% at $0.3763. No new same-company headline was identified in the current news window.
企業概要
事業概要
NeuroSense Therapeutics is a biotechnology company focused on neurodegenerative diseases such as ALS and related conditions. Its story centers on trying to develop therapies for some of the hardest diseases in CNS medicine.
所在地とセクター分類
NeuroSense is headquartered in Israel and listed in the U.S. market. It sits in neuroscience biotechnology.
ビジネスモデルの特徴
The company depends on clinical proof, translational confidence, and capital efficiency while advancing a narrow neurologic pipeline. Investors usually watch early data and strategic developments.
バイオ業界での位置付け
NeuroSense occupies a high-catalyst neurodegeneration niche within biotech. The stock is highly dependent on whether its programs can show meaningful neurologic benefit.
今後のカタリスト
- NeuroSense’s catalysts are primeC and its neurodegeneration programs, plus any update that shows the platform can still keep moving. The company still needs human proof.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。